Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

Bibliographic Details
Title: Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study
Authors: Scagliotti, Giorgio V., Park, Keunchil, Patil, Shekar, Rolski, Janusz, Goksel, Tuncay, Martins, Renato, Gans, Steven J.M., Visseren-Grul, Carla, Peterson, Patrick
Source: In European Journal of Cancer 2009 45(13):2298-2303
Database: ScienceDirect
More Details
ISSN:09598049
DOI:10.1016/j.ejca.2009.04.033
Published in:European Journal of Cancer
Language:English